AAPK1_HUMAN - dbPTM
AAPK1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AAPK1_HUMAN
UniProt AC Q13131
Protein Name 5'-AMP-activated protein kinase catalytic subunit alpha-1
Gene Name PRKAA1
Organism Homo sapiens (Human).
Sequence Length 559
Subcellular Localization Cytoplasm . Nucleus . In response to stress, recruited by p53/TP53 to specific promoters.
Protein Description Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. In response to nutrient limitation, phosphorylates transcription factor FOXO3 promoting FOXO3 mitochontrial import (By similarity). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1..
Protein Sequence MRRLSSWRKMATAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTYSKMSLQLYQVDSRTYLLDFRSIDDEITEAKSGTATPQRSGSVSNYRSCQRSDSDAEAQGKSSEVSLTSSVTSLDSSPVDLTPRPGSHTIEFFEMCANLIKILAQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MRRLSSWRKMAT
---CCCHHHHHHHHH
26.5028674151
6Phosphorylation--MRRLSSWRKMATA
--CCCHHHHHHHHHH
35.1846163063
22UbiquitinationKQKHDGRVKIGHYIL
HHCCCCCEEEEEEEC
6.9222817900
27UbiquitinationGRVKIGHYILGDTLG
CCEEEEEEECCCCEE
7.8222817900
32PhosphorylationGHYILGDTLGVGTFG
EEEECCCCEECCCCC
24.5028857561
37PhosphorylationGDTLGVGTFGKVKVG
CCCEECCCCCEEEEC
27.1528857561
40AcetylationLGVGTFGKVKVGKHE
EECCCCCEEEECCEE
34.3925953088
40UbiquitinationLGVGTFGKVKVGKHE
EECCCCCEEEECCEE
34.3919608861
40 (in isoform 2)Ubiquitination-34.39-
45UbiquitinationFGKVKVGKHELTGHK
CCEEEECCEECCCCE
36.5729967540
52AcetylationKHELTGHKVAVKILN
CEECCCCEEHHHHHC
32.9825953088
52UbiquitinationKHELTGHKVAVKILN
CEECCCCEEHHHHHC
32.9829967540
54UbiquitinationELTGHKVAVKILNRQ
ECCCCEEHHHHHCHH
11.1624816145
56UbiquitinationTGHKVAVKILNRQKI
CCCEEHHHHHCHHHC
31.5729967540
56 (in isoform 2)Ubiquitination-31.57-
65PhosphorylationLNRQKIRSLDVVGKI
HCHHHCCCCHHHHHH
32.1828857561
71AcetylationRSLDVVGKIRREIQN
CCCHHHHHHHHHHHC
22.7925953088
71UbiquitinationRSLDVVGKIRREIQN
CCCHHHHHHHHHHHC
22.7933845483
80AcetylationRREIQNLKLFRHPHI
HHHHHCCCCCCCHHH
53.8022637185
80UbiquitinationRREIQNLKLFRHPHI
HHHHHCCCCCCCHHH
53.8024816145
80 (in isoform 2)Malonylation-53.8026320211
130UbiquitinationDEKESRRLFQQILSG
CHHHHHHHHHHHHHC
4.4029967540
138UbiquitinationFQQILSGVDYCHRHM
HHHHHHCCHHHHHHC
4.2121963094
139UbiquitinationQQILSGVDYCHRHMV
HHHHHCCHHHHHHCE
43.8221963094
140UbiquitinationQILSGVDYCHRHMVV
HHHHCCHHHHHHCEE
6.4322817900
152UbiquitinationMVVHRDLKPENVLLD
CEECCCCCHHHEEEE
55.35-
154UbiquitinationVHRDLKPENVLLDAH
ECCCCCHHHEEEEHH
59.3821963094
165UbiquitinationLDAHMNAKIADFGLS
EEHHHCHHHHCCCHH
33.1621963094
167 (in isoform 2)Ubiquitination-12.84-
172PhosphorylationKIADFGLSNMMSDGE
HHHCCCHHHCCCCCC
24.0622322096
174PhosphorylationADFGLSNMMSDGEFL
HCCCHHHCCCCCCHH
2.158910387
175PhosphorylationDFGLSNMMSDGEFLR
CCCHHHCCCCCCHHH
3.7518669648
176PhosphorylationFGLSNMMSDGEFLRT
CCHHHCCCCCCHHHH
31.5326657352
178PhosphorylationLSNMMSDGEFLRTSC
HHHCCCCCCHHHHCC
21.9018220336
180UbiquitinationNMMSDGEFLRTSCGS
HCCCCCCHHHHCCCC
7.3721963094
183PhosphorylationSDGEFLRTSCGSPNY
CCCCHHHHCCCCCCC
30.4322322096
184PhosphorylationDGEFLRTSCGSPNYA
CCCHHHHCCCCCCCC
15.2822322096
185S-nitrosylationGEFLRTSCGSPNYAA
CCHHHHCCCCCCCCC
6.552212679
187PhosphorylationFLRTSCGSPNYAAPE
HHHHCCCCCCCCCCH
17.8222322096
190PhosphorylationTSCGSPNYAAPEVIS
HCCCCCCCCCCHHHC
13.9226552605
197PhosphorylationYAAPEVISGRLYAGP
CCCCHHHCCCCCCCC
24.0426552605
198PhosphorylationAAPEVISGRLYAGPE
CCCHHHCCCCCCCCC
16.7027251275
199UbiquitinationAPEVISGRLYAGPEV
CCHHHCCCCCCCCCC
20.1021963094
227UbiquitinationCGTLPFDDDHVPTLF
HCCCCCCCCCHHHHH
48.5821963094
243PhosphorylationKICDGIFYTPQYLNP
HHCCCCCCCHHHCCH
18.6521406692
244PhosphorylationICDGIFYTPQYLNPS
HCCCCCCCHHHCCHH
7.9921406692
247PhosphorylationGIFYTPQYLNPSVIS
CCCCCHHHCCHHHHH
15.0621406692
251PhosphorylationTPQYLNPSVISLLKH
CHHHCCHHHHHHHHH
30.8921406692
254PhosphorylationYLNPSVISLLKHMLQ
HCCHHHHHHHHHHHC
26.0324719451
254UbiquitinationYLNPSVISLLKHMLQ
HCCHHHHHHHHHHHC
26.0322817900
259UbiquitinationVISLLKHMLQVDPMK
HHHHHHHHHCCCCCC
2.4022817900
266UbiquitinationMLQVDPMKRATIKDI
HHCCCCCCCCCHHHH
44.2429967540
269PhosphorylationVDPMKRATIKDIREH
CCCCCCCCHHHHHHC
32.37-
269UbiquitinationVDPMKRATIKDIREH
CCCCCCCCHHHHHHC
32.3722817900
271UbiquitinationPMKRATIKDIREHEW
CCCCCCHHHHHHCHH
42.6329967540
274UbiquitinationRATIKDIREHEWFKQ
CCCHHHHHHCHHHHC
49.7222817900
276 (in isoform 1)Ubiquitination-27.9521906983
280UbiquitinationIREHEWFKQDLPKYL
HHHCHHHHCCCCHHC
43.9322817900
281UbiquitinationREHEWFKQDLPKYLF
HHCHHHHCCCCHHCC
48.2629967540
281 (in isoform 2)Ubiquitination-48.26-
285UbiquitinationWFKQDLPKYLFPEDP
HHHCCCCHHCCCCCC
62.9821906983
286PhosphorylationFKQDLPKYLFPEDPS
HHCCCCHHCCCCCCC
16.1928796482
286UbiquitinationFKQDLPKYLFPEDPS
HHCCCCHHCCCCCCC
16.1929967540
291 (in isoform 2)Ubiquitination-37.3721906983
293PhosphorylationYLFPEDPSYSSTMID
HCCCCCCCCCCCCCC
50.3928796482
294PhosphorylationLFPEDPSYSSTMIDD
CCCCCCCCCCCCCCH
16.4228796482
295PhosphorylationFPEDPSYSSTMIDDE
CCCCCCCCCCCCCHH
24.5428796482
295UbiquitinationFPEDPSYSSTMIDDE
CCCCCCCCCCCCCHH
24.5422817900
295 (in isoform 2)Ubiquitination-24.54-
296PhosphorylationPEDPSYSSTMIDDEA
CCCCCCCCCCCCHHH
17.4828796482
297PhosphorylationEDPSYSSTMIDDEAL
CCCCCCCCCCCHHHH
16.5328796482
300UbiquitinationSYSSTMIDDEALKEV
CCCCCCCCHHHHHHH
36.5522817900
309PhosphorylationEALKEVCEKFECSEE
HHHHHHHHHCCCCHH
66.9927642862
346PhosphorylationIDNRRIMNEAKDFYL
HCCHHHHHHHHCEEE
43.6418669648
347PhosphorylationDNRRIMNEAKDFYLA
CCHHHHHHHHCEEEE
39.4518669648
350PhosphorylationRIMNEAKDFYLATSP
HHHHHHHCEEEECCC
44.4627642862
352PhosphorylationMNEAKDFYLATSPPD
HHHHHCEEEECCCCC
12.9329255136
355PhosphorylationAKDFYLATSPPDSFL
HHCEEEECCCCCCCC
38.8929255136
356PhosphorylationKDFYLATSPPDSFLD
HCEEEECCCCCCCCC
28.9129255136
360PhosphorylationLATSPPDSFLDDHHL
EECCCCCCCCCCCCC
33.2229255136
367PhosphorylationSFLDDHHLTRPHPER
CCCCCCCCCCCCCCC
3.7927642862
368PhosphorylationFLDDHHLTRPHPERV
CCCCCCCCCCCCCCC
37.4923663014
370PhosphorylationDDHHLTRPHPERVPF
CCCCCCCCCCCCCCE
41.9924719451
370UbiquitinationDDHHLTRPHPERVPF
CCCCCCCCCCCCCCE
41.9921963094
372UbiquitinationHHLTRPHPERVPFLV
CCCCCCCCCCCCEEE
33.5022817900
373PhosphorylationHLTRPHPERVPFLVA
CCCCCCCCCCCEEEE
64.3818669648
375PhosphorylationTRPHPERVPFLVAET
CCCCCCCCCEEEECC
3.6127642862
382PhosphorylationVPFLVAETPRARHTL
CCEEEECCHHHCCCH
14.3429255136
385UbiquitinationLVAETPRARHTLDEL
EEECCHHHCCCHHHH
14.6021963094
387UbiquitinationAETPRARHTLDELNP
ECCHHHCCCHHHHCC
29.7822817900
387 (in isoform 1)Ubiquitination-29.7821906983
388PhosphorylationETPRARHTLDELNPQ
CCHHHCCCHHHHCCC
30.2823663014
396UbiquitinationLDELNPQKSKHQGVR
HHHHCCCCCCCCCCH
63.8321906983
397PhosphorylationDELNPQKSKHQGVRK
HHHCCCCCCCCCCHH
30.0728857561
398UbiquitinationELNPQKSKHQGVRKA
HHCCCCCCCCCCHHH
47.1622817900
402 (in isoform 2)Ubiquitination-4.5821906983
403PhosphorylationKSKHQGVRKAKWHLG
CCCCCCCHHHHHCCC
39.7927251275
406SumoylationHQGVRKAKWHLGIRS
CCCCHHHHHCCCCCC
37.88-
406SumoylationHQGVRKAKWHLGIRS
CCCCHHHHHCCCCCC
37.88-
406UbiquitinationHQGVRKAKWHLGIRS
CCCCHHHHHCCCCCC
37.88-
411UbiquitinationKAKWHLGIRSQSRPN
HHHHCCCCCCCCCCC
4.8821963094
411 (in isoform 2)Ubiquitination-4.88-
413UbiquitinationKWHLGIRSQSRPNDI
HHCCCCCCCCCCCHH
30.5022817900
421 (in isoform 2)Malonylation-2.6532601280
421 (in isoform 2)Ubiquitination-2.65-
429AcetylationAEVCRAIKQLDYEWK
HHHHHHHHHCCCEEE
43.7725953088
429UbiquitinationAEVCRAIKQLDYEWK
HHHHHHHHHCCCEEE
43.7729967540
431UbiquitinationVCRAIKQLDYEWKVV
HHHHHHHCCCEEEEE
6.8621963094
441PhosphorylationEWKVVNPYYLRVRRK
EEEEECCEEEEEEEC
15.2151241
442PhosphorylationWKVVNPYYLRVRRKN
EEEECCEEEEEEECC
6.8451247
444UbiquitinationVVNPYYLRVRRKNPV
EECCEEEEEEECCCC
12.0829967540
444 (in isoform 2)Ubiquitination-12.08-
446UbiquitinationNPYYLRVRRKNPVTS
CCEEEEEEECCCCCC
37.1021963094
448UbiquitinationYYLRVRRKNPVTSTY
EEEEEEECCCCCCCC
55.8529967540
457UbiquitinationPVTSTYSKMSLQLYQ
CCCCCCEEEEEEEEE
23.3021963094
459UbiquitinationTSTYSKMSLQLYQVD
CCCCEEEEEEEEEEC
19.3921963094
463PhosphorylationSKMSLQLYQVDSRTY
EEEEEEEEEECCCEE
8.118391907
463UbiquitinationSKMSLQLYQVDSRTY
EEEEEEEEEECCCEE
8.1129967540
467PhosphorylationLQLYQVDSRTYLLDF
EEEEEECCCEEEEEE
27.8919060867
472UbiquitinationVDSRTYLLDFRSIDD
ECCCEEEEEECCCCH
4.0521963094
473PhosphorylationDSRTYLLDFRSIDDE
CCCEEEEEECCCCHH
34.0318669648
474UbiquitinationSRTYLLDFRSIDDEI
CCEEEEEECCCCHHH
7.1421963094
476PhosphorylationTYLLDFRSIDDEITE
EEEEEECCCCHHHHC
30.2928176443
476 (in isoform 1)Ubiquitination-30.2921906983
477PhosphorylationYLLDFRSIDDEITEA
EEEEECCCCHHHHCC
7.2518669648
479PhosphorylationLDFRSIDDEITEAKS
EEECCCCHHHHCCCC
47.7518669648
481PhosphorylationFRSIDDEITEAKSGT
ECCCCHHHHCCCCCC
5.6218669648
482PhosphorylationRSIDDEITEAKSGTA
CCCCHHHHCCCCCCC
28.0428176443
485UbiquitinationDDEITEAKSGTATPQ
CHHHHCCCCCCCCCC
43.0921906983
486PhosphorylationDEITEAKSGTATPQR
HHHHCCCCCCCCCCC
48.7222322096
487PhosphorylationEITEAKSGTATPQRS
HHHCCCCCCCCCCCC
20.7518669648
488PhosphorylationITEAKSGTATPQRSG
HHCCCCCCCCCCCCC
34.1522322096
490PhosphorylationEAKSGTATPQRSGSV
CCCCCCCCCCCCCCC
21.5722322096
491 (in isoform 2)Ubiquitination-25.7321906983
494PhosphorylationGTATPQRSGSVSNYR
CCCCCCCCCCCCCCC
30.1225159151
496PhosphorylationATPQRSGSVSNYRSC
CCCCCCCCCCCCCCC
24.5022322096
498PhosphorylationPQRSGSVSNYRSCQR
CCCCCCCCCCCCCCC
29.8221955146
500PhosphorylationRSGSVSNYRSCQRSD
CCCCCCCCCCCCCCC
9.0827362937
500UbiquitinationRSGSVSNYRSCQRSD
CCCCCCCCCCCCCCC
9.0821963094
500 (in isoform 2)Ubiquitination-9.08-
501PhosphorylationSGSVSNYRSCQRSDS
CCCCCCCCCCCCCCC
34.9027251275
502PhosphorylationGSVSNYRSCQRSDSD
CCCCCCCCCCCCCCC
12.3026552605
503PhosphorylationSVSNYRSCQRSDSDA
CCCCCCCCCCCCCCH
2.6327251275
506PhosphorylationNYRSCQRSDSDAEAQ
CCCCCCCCCCCHHHC
18.658546373
508PhosphorylationRSCQRSDSDAEAQGK
CCCCCCCCCHHHCCC
39.7128102081
511PhosphorylationQRSDSDAEAQGKSSE
CCCCCCHHHCCCCCE
46.6624719451
515UbiquitinationSDAEAQGKSSEVSLT
CCHHHCCCCCEEEEE
38.43-
516PhosphorylationDAEAQGKSSEVSLTS
CHHHCCCCCEEEEEE
38.2623663014
517PhosphorylationAEAQGKSSEVSLTSS
HHHCCCCCEEEEEEC
45.5723663014
520PhosphorylationQGKSSEVSLTSSVTS
CCCCCEEEEEECCEE
23.1325072903
521PhosphorylationGKSSEVSLTSSVTSL
CCCCEEEEEECCEEC
6.9533259812
522PhosphorylationKSSEVSLTSSVTSLD
CCCEEEEEECCEECC
16.0825072903
523PhosphorylationSSEVSLTSSVTSLDS
CCEEEEEECCEECCC
28.2730631047
524PhosphorylationSEVSLTSSVTSLDSS
CEEEEEECCEECCCC
24.9530631047
526PhosphorylationVSLTSSVTSLDSSPV
EEEEECCEECCCCCC
26.0630631047
527PhosphorylationSLTSSVTSLDSSPVD
EEEECCEECCCCCCC
28.2030631047
530PhosphorylationSSVTSLDSSPVDLTP
ECCEECCCCCCCCCC
41.6625072903
531PhosphorylationSVTSLDSSPVDLTPR
CCEECCCCCCCCCCC
28.7123663014
536PhosphorylationDSSPVDLTPRPGSHT
CCCCCCCCCCCCCCH
16.8826074081
538PhosphorylationSPVDLTPRPGSHTIE
CCCCCCCCCCCCHHH
42.8727251275
541PhosphorylationDLTPRPGSHTIEFFE
CCCCCCCCCHHHHHH
21.8226074081
543PhosphorylationTPRPGSHTIEFFEMC
CCCCCCCHHHHHHHH
24.7326074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
174TPhosphorylationKinaseAMPK_GROUP-PhosphoELM
174TPhosphorylationKinaseSTK11Q15831
PhosphoELM
183TPhosphorylationKinaseCAMK2BQ13554
PSP
183TPhosphorylationKinaseAMPK-FAMILY-GPS
183TPhosphorylationKinaseLKB1Q9WTK7
PSP
183TPhosphorylationKinaseSTK11Q15831
GPS
183TPhosphorylationKinaseMAP3K11Q16584
GPS
183TPhosphorylationKinaseCAMKK2Q96RR4
Uniprot
183TPhosphorylationKinaseCAMKK1Q8N5S9
PSP
183TPhosphorylationKinaseBRSK1Q8TDC3-2
GPS
183TPhosphorylationKinaseBRSK2Q8IWQ3
PSP
183TPhosphorylationKinasePRKAA1Q13131
GPS
360SPhosphorylationKinasePRKAA1Q13131
GPS
360SPhosphorylationKinaseULK1O75385
Uniprot
368TPhosphorylationKinaseULK1O75385
Uniprot
388TPhosphorylationKinasePRKAA1Q13131
GPS
482TPhosphorylationKinaseGSK3BP49841
PSP
486SPhosphorylationKinaseGSK3BP49841
PSP
486SPhosphorylationKinasePRKAA1Q13131
GPS
490TPhosphorylationKinaseGSK3AP49840
PSP
490TPhosphorylationKinaseGSK3BP49841
PSP
494SPhosphorylationKinaseAKT1P31749
PSP
494SPhosphorylationKinasePRKAA1Q13131
GPS
496SPhosphorylationKinasePRKAA1Q13131
GPS
496SPhosphorylationKinasePRKCBP05771
GPS
496SPhosphorylationKinasePRKCAP17252
GPS
496SPhosphorylationKinasePKCAP04409
PSP
496SPhosphorylationKinaseAKT1P31749
PSP
-KUbiquitinationE3 ubiquitin ligaseTRIM28Q13263
PMID:25945414

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
183TPhosphorylation

14976552
183TPhosphorylation

14976552
183TPhosphorylation

14976552

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AAPK1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MTOR_HUMANMTORphysical
14970221
TSC2_HUMANTSC2physical
14651849
TSC2_HUMANTSC2physical
15261145
FNIP1_HUMANFNIP1physical
17028174
CFTR_HUMANCFTRphysical
10862786
IF2P_HUMANEIF5Bphysical
20562859
AAKG1_HUMANPRKAG1physical
20562859
SP16H_HUMANSUPT16Hphysical
20562859
FXR2_HUMANFXR2physical
20562859
PA2G4_HUMANPA2G4physical
20562859
SND1_HUMANSND1physical
20562859
G3BP1_HUMANG3BP1physical
20562859
PARP1_HUMANPARP1physical
20562859
FMR1_HUMANFMR1physical
20562859
AAKB2_HUMANPRKAB2physical
20562859
AAKB1_HUMANPRKAB1physical
20562859
RL35_HUMANRPL35physical
20562859
HS90A_HUMANHSP90AA1physical
16306228
HSP74_HUMANHSPA4physical
16306228
TBA1A_HUMANTUBA1Aphysical
16306228
CDC37_HUMANCDC37physical
16306228
AAKB1_HUMANPRKAB1physical
16306228
AAKG1_HUMANPRKAG1physical
16306228
AAKB2_HUMANPRKAB2physical
16306228
SIK3_HUMANSIK3physical
16306228
1433Z_HUMANYWHAZphysical
16306228
1433E_HUMANYWHAEphysical
16306228
SIK1_HUMANSIK1physical
16306228
SIK2_HUMANSIK2physical
16306228
TERA_HUMANVCPphysical
16306228
2AAB_HUMANPPP2R1Bphysical
16306228
PP2AA_HUMANPPP2CAphysical
16306228
UBP2_HUMANUSP2physical
16306228
NUAK1_HUMANNUAK1physical
16306228
NUAK2_HUMANNUAK2physical
16306228
BRSK1_HUMANBRSK1physical
16306228
BRSK2_HUMANBRSK2physical
16306228
MARK1_HUMANMARK1physical
16306228
MARK2_HUMANMARK2physical
16306228
MARK3_HUMANMARK3physical
16306228
MARK4_HUMANMARK4physical
16306228
SNRK_HUMANSNRKphysical
16306228
CFTR_HUMANCFTRphysical
20861072
PSD11_HUMANPSMD11physical
19616115
CRBN_HUMANCRBNphysical
21232561
AAKB1_HUMANPRKAB1physical
21232561
AAKG1_HUMANPRKAG1physical
21232561
EPM2A_HUMANEPM2Aphysical
21728993
RPTOR_HUMANRPTORphysical
18439900
HDAC5_HUMANHDAC5physical
22462548
CRTC2_HUMANCRTC2physical
22462548
ABI1_HUMANABI1physical
20368287
SDE2_MOUSESde2physical
20368287
MTFR2_MOUSEMtfr2physical
20368287
XRN2_MOUSEXrn2physical
20368287
ABI1_MOUSEAbi1physical
20368287
AAKG1_MOUSEPrkag1physical
20368287
AAKG2_MOUSEPrkag2physical
20368287
CHERP_MOUSECherpphysical
20368287
EMIL1_MOUSEEmilin1physical
20368287
RHG22_MOUSEArhgap22physical
20368287
LZTS2_MOUSELzts2physical
20368287
MAGD1_MOUSEMaged1physical
20368287
NAB2_MOUSENab2physical
20368287
NRBF2_MOUSENrbf2physical
20368287
AAKB1_MOUSEPrkab1physical
20368287
RC3H1_MOUSERc3h1physical
20368287
SRBS1_MOUSESorbs1physical
20368287
TFPT_MOUSETfptphysical
20368287
THAP7_MOUSEThap7physical
20368287
TRIP6_MOUSETrip6physical
20368287
CBPE_HUMANCPEphysical
20368287
APT_MOUSEAprtphysical
20368287
BHE40_MOUSEBhlhe40physical
20368287
CBPE_MOUSECpephysical
20368287
HSPB1_MOUSEHspb1physical
20368287
KIF1C_MOUSEKif1cphysical
20368287
NEDD1_MOUSENedd1physical
20368287
AAKB2_HUMANPRKAB2physical
21988832
MDM4_HUMANMDM4physical
24190973
AAKB2_HUMANPRKAB2physical
23455922
HS90A_HUMANHSP90AA1physical
23455922
HS90B_HUMANHSP90AB1physical
23455922
AAKG1_HUMANPRKAG1physical
23455922
ACACA_HUMANACACAphysical
23455922
FKBP5_HUMANFKBP5physical
23455922
AAKG2_HUMANPRKAG2physical
23455922
AAKB1_HUMANPRKAB1physical
23455922
ACACA_HUMANACACAphysical
18480843
P53_MOUSETrp53physical
15866171
AAKB1_HUMANPRKAB1physical
8621713
AAKG1_HUMANPRKAG1physical
8621713
AAKB1_HUMANPRKAB1physical
8663446
AAKG1_HUMANPRKAG1physical
8663446
AAKB2_HUMANPRKAB2physical
25416956
AAKG1_HUMANPRKAG1physical
25416956
TRI27_HUMANTRIM27physical
25416956
VPS52_HUMANVPS52physical
25416956
TRIP6_HUMANTRIP6physical
25416956
BHE40_HUMANBHLHE40physical
25416956
ZBED1_HUMANZBED1physical
25416956
ABI2_HUMANABI2physical
25416956
RBPMS_HUMANRBPMSphysical
25416956
IKZF3_HUMANIKZF3physical
25416956
MTUS2_HUMANMTUS2physical
25416956
FSBP_HUMANRAD54Bphysical
25416956
RA54B_HUMANRAD54Bphysical
25416956
ROP1A_HUMANROPN1physical
25416956
THAP1_HUMANTHAP1physical
25416956
HOMEZ_HUMANHOMEZphysical
25416956
HMBX1_HUMANHMBOX1physical
25416956
VP37B_HUMANVPS37Bphysical
25416956
T22D4_HUMANTSC22D4physical
25416956
LMBL3_HUMANL3MBTL3physical
25416956
RIM3A_HUMANRIMBP3physical
25416956
UBX11_HUMANUBXN11physical
25416956
PNMA5_HUMANPNMA5physical
25416956
ADIP_HUMANSSX2IPphysical
25416956
K1C40_HUMANKRT40physical
25416956
RFX6_HUMANRFX6physical
25416956
IN80E_HUMANINO80Ephysical
25416956
TXNIP_HUMANTXNIPphysical
23453806
EP300_HUMANEP300physical
21567395
PPM1F_HUMANPPM1Fphysical
20801214
FKBP5_HUMANFKBP5physical
25852190
AAKB1_HUMANPRKAB1physical
25852190
AAKB2_HUMANPRKAB2physical
25852190
AAKG1_HUMANPRKAG1physical
25852190
SUN2_HUMANSUN2physical
25852190
UBP10_HUMANUSP10physical
26876938
FANCG_HUMANFANCGphysical
27449087
FANCA_HUMANFANCAphysical
27449087
GLI1_HUMANGLI1physical
28562331
CYC_BOVINCYCSphysical
27758862

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00945Acetylsalicylic acid
DB00131Adenosine monophosphate
DB00171Adenosine triphosphate
DB00914Phenformin
Regulatory Network of AAPK1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-32; THR-183; SER-184;SER-187; THR-355; SER-356; SER-397; TYR-441; SER-467; SER-476;SER-486; THR-488; THR-490; SER-496; SER-502; SER-506; SER-508;SER-516; SER-520; THR-522; SER-523; SER-524 AND SER-527, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-382; SER-486;THR-490 AND SER-496, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; SER-486; THR-490;SER-496; SER-508; SER-523 AND SER-527, AND MASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-382 AND THR-490, ANDMASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-382, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-442, AND MASSSPECTROMETRY.

TOP